A variant-proof, pan-coronavirus vaccine is on the horizon, now with the first starting a Phase 2 clinical trial. I had the privilege of teaming up with @dr_kkjetelina to write about it @SubstackInc https://t.co/dPxIBh6ocs
— Eric Topol (@EricTopol) December 26, 2021